CRISPR Therapeutics AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	4,576	4,972	3,183	5,799	10,818	3,362	1,483	963	807	-
Market Cap Growth	-	56.24%	-45.12%	-46.39%	221.74%	126.76%	53.94%	19.42%	-	-
Enterprise Value	3,109	3,506	1,600	3,628	9,172	2,466	1,023	720	488	-118
PE Ratio	-32.37	-32.37	-4.89	15.36	-31.01	50.29	-8.99	-14.09	-34.80	-
PS Ratio	12.33	13.40	2656.64	6.34	15045.33	11.61	474.62	23.49	156.18	-
PB Ratio	2.43	2.64	1.70	2.42	6.50	3.58	3.78	5.13	3.46	-
P/FCF Ratio	-18.43	-18.43	-5.97	12.68	-42.14	67.25	-14.97	-12.36	-14.43	-
P/OCF Ratio	-19.10	-19.10	-6.42	10.76	-45.38	59.32	-15.41	-13.74	-15.26	-
EV/Sales Ratio	8.38	9.44	1335.33	3.97	12756.39	8.52	327.43	17.57	94.47	-479.05
EV/EBITDA Ratio	-26.79	-26.79	-2.55	9.13	-27.07	34.23	-6.36	-11.33	-35.56	4.68
EV/EBIT Ratio	-23.26	-23.26	-2.46	9.56	-26.35	36.64	-6.22	-10.81	-33.32	4.66
EV/FCF Ratio	-12.99	-12.99	-3.00	7.93	-35.73	49.33	-10.33	-9.24	-8.73	-2.03
Debt / Equity Ratio	0.13	0.13	0.13	0.09	0.04	0.06	-	-	-	-1.32
Debt / EBITDA Ratio	-1.82	-1.82	-0.39	0.57	-0.18	0.73	-	-	-	-1.52
Debt / FCF Ratio	-0.88	-0.88	-0.46	0.49	-0.24	1.05	-	-	-	0.66
Quick Ratio	17.51	17.51	15.09	19.99	18.11	16.62	16.58	16.92	14.63	15.46
Current Ratio	17.54	17.54	15.30	20.17	18.21	17.29	16.81	17.12	14.56	15.45
Asset Turnover	0.17	0.17	0	0.35	0.00	0.42	0.01	0.14	0.02	0.00
Interest Coverage	-	-	-	-	-	-	-	-	-1.82	-235.07
Return on Equity (ROE)	-8.40%	-8.40%	-31.90%	16.20%	-29.00%	11.70%	-48.30%	-35.10%	-22.80%	140.80%
Return on Assets (ROA)	-7.00%	-7.00%	-26.90%	14.50%	-26.00%	9.60%	-38.00%	-23.20%	-9.20%	-31.70%
Return on Capital (ROIC)	-10.49%	-10.49%	-31.76%	14.16%	-20.54%	4.68%	-40.53%	-34.42%	-29.26%	-278.48%
Earnings Yield	-3.36%	-3.09%	-20.43%	6.51%	-3.22%	1.99%	-11.13%	-7.10%	-2.87%	-
FCF Yield	-5.90%	-5.43%	-16.74%	7.88%	-2.37%	1.49%	-6.68%	-8.09%	-6.93%	-
Buyback Yield / Dilution	-1.90%	-1.90%	3.29%	-21.90%	-15.84%	-18.70%	-19.74%	-226.80%	-143.33%	-41.50%
Total Shareholder Return	-1.90%	-1.90%	3.29%	-21.90%	-15.84%	-18.70%	-19.74%	-226.80%	-143.33%	-41.50%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).